Article
Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration
22 Dec 2016
Abstract excerpt
The enzyme poly-ADP-ribose-polymerase (PARP) mediates DNA-repair and rearrangements of the nuclear chromatin. Generally, PARP activity is thought to promote cell survival and in recent years a number of PARP inhibitors have been clinically developed for cancer treatment. Paradoxically, PARP activity is also connected to many diseases including the untreatable blinding disease Retinitis Pigmentosa (RP), where PARP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
